Sfoglia per AUTORE
SPADA M
Collezione ASL Cuneo 2
Items : 2
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study. in Frontiers in oncology / Front Oncol. 2024 Feb 12;14:1307635. doi: 10.3389/fonc.2024.1307635. eCollection 2024.
2024
ASL Cuneo 2
AO Ordine Mauriziano
ASL Cuneo 2
AO Ordine Mauriziano
Chiellino S; Galli L; Banna GL; Fornarini G; Rescigno P; Cremante M; Damassi A; Catalano F; Roviello G; Cavo A; Lipari H; Vignani F; Prati G; Spada M; Nolè F; Morelli F; Di Napoli M; Caffo O; Malgeri A; Atzori F; Prati V; Tudini M; Sorarù M; Mollica V; Ricotta R; Baldessari C; Procopio G; Milella M; Fratino L; et alii...
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001154. doi: 10.1136/jitc-2020-001154.
2020
ASL Cuneo 2
ASL Cuneo 2
Zivi A; Zampiva I; Zacchi F; von Arx C; Vivaldi C; Ventriglia J; Vitale MG; Vitiello F; Vari S; Trojanello C; Vanella V; Tomei F; Vincenzo T; Trapani D; Taveggia P; Tarantino P; Spada M; Silvestri A; Simeone E; Sbrana A; Santabarbara G; Ascierto PA; Salati M; Rossi A; Russo A; Rosanova M; Riccio V; Piccin L; Pignata S; et alii...